Sniper Medical Technologies
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Developer of FDA, CE, and NMPA-approved fully automated digital PCR systems for precision molecular diagnostics.
OncologyInfectious Diseases
Technology Platform
VibroJet® digital PCR technology enabling fully automated, integrated sample-to-result workflows with droplet-level quality control for high-precision nucleic acid quantification.
Opportunities
Growth is driven by expanding clinical adoption of dPCR for MRD monitoring in oncology and rapid point-of-care molecular testing, supported by its unique regulatory approvals across major markets.
Risk Factors
Key risks include intense competition from larger, well-capitalized diagnostic companies, the challenge of building a comprehensive assay menu, and potential pricing/reimbursement pressures in core markets.
Competitive Landscape
Competes with Bio-Rad and Thermo Fisher in digital PCR. Differentiates through claimed full automation, integrated workflow, and simultaneous FDA, CE, and NMPA approvals for its platform.